We do not publish a verdict for Revolution Medicines Inc (RVMD) and Vertex Pharmaceuticals Inc (VRTX) is overvalued.
We publish an intrinsic value for VRTX but not for RVMD, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
No Leak Score yet
Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $380.05; the price of $514.99 is 36% above that value, and 82% of that value comes from beyond year five.
Leak Score 65/100 on 9 of 12 signals
| Metric | RVMD | VRTX |
|---|---|---|
| Verdict | — | Overvalued |
| Price | $192.86 | $514.99 |
| Intrinsic value | — | $380.05 |
| Margin of safety | — | -36% |
| Leak Score | — | 65/100 (9/12) |
| Market cap | $41.3B | $130.5B |
| Revenue growth, 5 years | — | 14.2% |
| Operating margin | — | 39.5% |
| Net margin | — | 34.7% |
| Return on equity | -79.1% | 23.5% |
| Debt to equity | 0.46 | 0.10 |
| P/E | — | 30.0x |
| Forward P/E | — | 24.4x |
| P/B | 15.8x | 6.4x |